Development of an international standard set of outcome measures for patients with venous thromboembolism: an International Consortium for Health Outcomes Measurement consensus recommendation

Affiliations

• ¹ Academic Department of Vascular Surgery, Section of Vascular Risk and Surgery, School of Cardiovascular Medicine and Science, Guy's and Saint Thomas' Hospital, King's College London, London, UK; Academic Section of Vascular Surgery, Department of Surgery and Cancer and Department of Vascular Surgery, Imperial College Healthcare NHS Trust, Imperial College London, London, UK.
• ² Department of Medicine: Thrombosis and Haemostasis, Leiden University Medical Center, Leiden University, Leiden, Netherlands.
• ³ International Consortium for Health Outcomes Measurement, London, UK.
• ⁴ International Consortium for Health Outcomes Measurement, Boston, MA, USA.
• ⁵ Aalborg Thrombosis Research Unit, Department of Cardiology, Aalborg University Hospital, Aalborg University, Aalborg, Denmark.
• ⁶ Department of Surgery, University of Granada Medical School, University of Granada, Granada, Spain.
• ⁷ Department of Pulmonary Medicine, University of California, San Diego, CA, USA.
• ⁸ Clinical Division of Haematology and Haemostaseology, Department of Medicine I, Medical University of Vienna, Vienna, Austria.
• ⁹ Department of Angiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland; Centre for Thrombosis and Haemostasis, Johannes Gutenberg University Mainz, Mainz, Germany.
• ¹⁰ Department of Pulmonology and Thoracic Surgery, Hospital Moinhos de Vento, Porto Alegre, Rio Grande do Sul, Brazil; National Association of Private Hospitals, Porto Alegre, Rio Grande do Sul, Brazil.
• ¹¹ Lincoln Impact Literacy Institute, University of Lincoln, Lincoln, UK.
• ¹² Department of Vascular and Therapeutic Medicine, University Hospital of Saint-Étienne, University of Saint-Étienne, Saint-Étienne, France; CIC-1408, INSERM, University Hospital of Saint-Étienne, University of Saint-Étienne, Saint-Étienne, France; French Clinical Research Infrastructure Network [F-CRIN] INNOvenous thromboembolism, University Hospital of Saint-Étienne, University of Saint-Étienne, Saint-Étienne, France; UMR1059, INSERM, Université Jean-Monnet, Saint-Étienne, France.
• ¹³ Heart and Vascular Centre, Maastricht University Medical Centre, Maastricht University, Maastricht, Netherlands.
• ¹⁴ Department of Haematological Medicine, Guy's and Saint Thomas' Hospital, King's College London, London, UK.
• ¹⁵ Hematology Division, Brigham and Women's Hospital, Harvard Medical School, Harvard University, Boston, MA, USA.
• ¹⁶ Department of Medicine, Sunnybrook Health Sciences Centre and University of Toronto, Toronto, ON, Canada.
• ¹⁷ Division of Vascular Surgery, Department of Surgery, Stony Brook Hospital, Stony Brook, NY, USA.
• ¹⁸ Department of Medicine, Ottawa Hospital Research Institute, Ottawa, ON, Canada.
• ¹⁹ Department of Surgery, University of Washington, Seattle, WA, USA.
• ²⁰ Marie Curie Palliative Care Research Centre, Cardiff University, Cardiff, UK.
• ²¹ Department of Pulmonary Medicine, Amsterdam Cardiovascular Sciences, Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam, Netherlands.
• ²² Clínica San Felipe, Jesús María, Peru.
• ²³ Division of Angiology and Haemostasis, Geneva University Hospitals, University of Geneva, Geneva, Switzerland; Faculty of Medicine, University of Geneva, Geneva, Switzerland.
• ²⁴ Division of Hematology, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Harvard University, Boston, MA, USA.
• ²⁵ Department of Industrial Design, University of Technology Eindhoven, Eindhoven, Netherlands.
• ²⁶ Heart Lung Research Institute, Department of Medicine, University of Cambridge, Cambridge, UK.
• ²⁷ French Clinical Research Infrastructure Network [F-CRIN] INNOvenous thromboembolism, University Hospital of Saint-Étienne, University of Saint-Étienne, Saint-Étienne, France; Department of Internal Medicine and Pneumology, University Hospital of Brest, Brest, France; Group d'etude de la thrombose de Bretagne Occidentale, Université de Bretagne Occidentale, Brest, France.
• ²⁸ General Clinical Research Center, Taipei Veterans General Hospital, Taipei, Taiwan.
• ²⁹ Department of Clinical Sciences, Karolinska Institutet; Danderyd Hospital, Danderyd, Sweden.
• ³⁰ Department of Emergency Medicine, Queen's University, Kingston, ON, Canada; Departments of Medicine and Health Research Methods, Evidence and Impact, McMaster University, Hamilton, ON, Canada.
• ³¹ Academic Department of Vascular Surgery, Section of Vascular Risk and Surgery, School of Cardiovascular Medicine and Science, Guy's and Saint Thomas' Hospital, King's College London, London, UK.
• ³² Department of Medicine: Thrombosis and Haemostasis, Leiden University Medical Center, Leiden University, Leiden, Netherlands. Electronic address: f.a.klok@lumc.nl.